{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -1.7791834, "regularMarketPrice": 0.806, "exchange": "NCM", "shortName": "Genprex, Inc.", "longName": "Genprex, Inc.", "messageBoardId": "finmb_225557674", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "currency": "USD", "marketState": "PRE", "firstTradeDateMilliseconds": 1522330200000, "priceHint": 4, "fiftyTwoWeekLowChange": 0.06999999, "fiftyTwoWeekLowChangePercent": 0.09510869, "fiftyTwoWeekRange": "0.736 - 2.67", "fiftyTwoWeekHighChange": -1.8640001, "fiftyTwoWeekHighChangePercent": -0.6981273, "fiftyTwoWeekLow": 0.736, "fiftyTwoWeekHigh": 2.67, "earningsTimestamp": 1589486400, "earningsTimestampStart": 1589486400, "earningsTimestampEnd": 1589486400, "trailingAnnualDividendRate": 0.0, "epsTrailingTwelveMonths": -0.5, "epsForward": -0.51, "epsCurrentYear": -0.49, "priceEpsCurrentYear": -1.6448979, "sharesOutstanding": 51979100, "bookValue": 0.463, "fiftyDayAverage": 0.8699, "fiftyDayAverageChange": -0.063899994, "fiftyDayAverageChangePercent": -0.07345671, "twoHundredDayAverage": 1.303425, "twoHundredDayAverageChange": -0.49742496, "twoHundredDayAverageChangePercent": -0.38162914, "marketCap": 41895156, "forwardPE": -1.5803921, "priceToBook": 1.7408208, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.014599979, "regularMarketTime": 1684180800, "regularMarketDayHigh": 0.82, "regularMarketDayRange": "0.8 - 0.82", "regularMarketDayLow": 0.8, "regularMarketVolume": 80930, "regularMarketPreviousClose": 0.8206, "bid": 0.0, "ask": 0.0, "bidSize": 22, "askSize": 18, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 0.8, "averageDailyVolume3Month": 590636, "averageDailyVolume10Day": 133620, "trailingAnnualDividendYield": 0.0, "displayName": "Genprex", "symbol": "GNPX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "3300 Bee Cave Road", "address2": "Suite 650-227", "city": "Austin", "state": "TX", "zip": "78746", "country": "United States", "phone": "(877) 774-4679", "website": "https://www.genprex.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Rodney Varner", "age": 65, "title": "Co-Founder, Chairman, Pres & CEO", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 886974, "fmt": "886.97k", "longFmt": "886,974"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 316330, "fmt": "316.33k", "longFmt": "316,330"}}, {"maxAge": 1, "name": "Mr. Ryan M. Confer M.S.", "age": 40, "title": "Chief Financial Officer", "yearBorn": 1982, "fiscalYear": 2022, "totalPay": {"raw": 606572, "fmt": "606.57k", "longFmt": "606,572"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 79084, "fmt": "79.08k", "longFmt": "79,084"}}, {"maxAge": 1, "name": "Ms. Catherine M. Vaczy Esq.", "age": 61, "title": "Exec. VP, Gen. Counsel, Corp. Sec. & Chief Strategy Officer", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 704935, "fmt": "704.93k", "longFmt": "704,935"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Hemant  Kumar C.P.M., EMBA, Ph.D.", "age": 59, "title": "Chief Manufacturing & Technology Officer", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David M. Schloss", "title": "Sr. VP of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Thomas C. Gallagher Esq.", "title": "Sr. VP of Intellectual Property & Licensing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. William E. Gannon Jr.", "title": "Member of Clinical Advisory Board & VP of Regulatory Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Mark S. Berger M.D.", "age": 67, "title": "Chief Medical Officer", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jack A. Roth F.A.C.S., FACS, M.D.", "title": "Chairman of Scientific & Medical Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}